CRISPR/Cas9 technology in the modeling of and treatment of mucopolysaccharidosis
Mucopolysaccharidosis (MPS) syndromes are a group of heterogeneous genetic disorders in terms of genetic basis and clinical manifestations, ranging from mild to fatal forms. There are a number of applied or prospective treatment modalities for MPS, including bone marrow transplantation, enzyme repla...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Elsevier
2024-09-01
|
| Seria: | Biochemistry and Biophysics Reports |
| Hasła przedmiotowe: | |
| Dostęp online: | http://www.sciencedirect.com/science/article/pii/S2405580824001353 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|